标题
How can attrition rates be reduced in cancer drug discovery?
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 8, Issue 4, Pages 363-368
出版商
Informa Healthcare
发表日期
2013-02-04
DOI
10.1517/17460441.2013.768984
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer
- (2012) Adrian Britschgi et al. CANCER CELL
- Accelerating Cancer Therapy Development: The Importance of Combination Strategies and Collaboration. Summary of an Institute of Medicine Workshop
- (2012) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Improving Publication Rates of Biomarker Results from Cancer Trials
- (2012) R. Iannone CLINICAL CANCER RESEARCH
- Publication and Reporting Conduct for Pharmacodynamic Analyses of Tumor Tissue in Early-Phase Oncology Trials
- (2012) G. A. Freeman et al. CLINICAL CANCER RESEARCH
- Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
- (2012) C. Gasch et al. CLINICAL CHEMISTRY
- A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer
- (2012) J. Rodríguez-Pascual et al. INVESTIGATIONAL NEW DRUGS
- Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
- (2012) A S Moore et al. LEUKEMIA
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
- (2012) L. J. Valentijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Valley of Death in anticancer drug development: a reassessment
- (2012) David J. Adams TRENDS IN PHARMACOLOGICAL SCIENCES
- Medicines for pediatric oncology: can we overcome the failure to deliver?
- (2012) Agnes Saint-Raymond et al. Expert Review of Clinical Pharmacology
- Applicability of a "Pick a Winner" trial design to acute myeloid leukemia
- (2011) R. K. Hills et al. BLOOD
- Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR
- (2011) Areti Strati et al. BMC CANCER
- Targeting IGF-1R: throwing out the baby with the bathwater?
- (2011) B Basu et al. BRITISH JOURNAL OF CANCER
- Targeted agents: How to select the winners in preclinical and early clinical studies?
- (2011) Rachel Goodwin et al. EUROPEAN JOURNAL OF CANCER
- NCATS Could Mitigate Pharma Valley of Death
- (2011) John C. Reed et al. Genetic Engineering & Biotechnology News
- Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice
- (2011) Francesco Trotta et al. JOURNAL OF CLINICAL ONCOLOGY
- Opportunities and Challenges in the Development of Experimental Drug Combinations for Cancer
- (2011) R. W. Humphrey et al. JNCI-Journal of the National Cancer Institute
- A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
- (2011) M. Hidalgo et al. MOLECULAR CANCER THERAPEUTICS
- The inverted pyramid of biomarker-driven trials
- (2011) Ignacio Garrido-Laguna et al. Nature Reviews Clinical Oncology
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- Genetically engineered murine models – Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma
- (2011) Louis Chesler et al. SEMINARS IN CANCER BIOLOGY
- Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs
- (2010) J Cummings et al. BRITISH JOURNAL OF CANCER
- PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
- (2010) J. Dupont Jensen et al. CLINICAL CANCER RESEARCH
- The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
- (2010) L. Seymour et al. CLINICAL CANCER RESEARCH
- Preclinical drug development for childhood cancer
- (2010) Lucas Moreno et al. Expert Opinion on Drug Discovery
- Adaptive design clinical trials: Methodology, challenges and prospect
- (2010) Rajiv Mahajan et al. INDIAN JOURNAL OF PHARMACOLOGY
- Productivity Shortfalls in Drug Discovery: Contributions from the Preclinical Sciences?
- (2010) M. Williams JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Anticancer drug development: the grand challenges
- (2010) William N. Hait NATURE REVIEWS DRUG DISCOVERY
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Some drop-the-loser designs for monitoring multiple doses
- (2010) Y. H. Joshua Chen et al. STATISTICS IN MEDICINE
- Randomized Phase II Designs
- (2009) L. Rubinstein et al. CLINICAL CANCER RESEARCH
- Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
- (2009) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- (2009) R. L. Yauch et al. SCIENCE
- Do molecularly targeted agents in oncology have reduced attrition rates?
- (2008) Ian Walker et al. NATURE REVIEWS DRUG DISCOVERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started